Clinical Trial Update: Sildenafil for Post-capillary Pulmonary Hypertension in Patients Undergoing Cardiac Surgery [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated sildenafil for post-capillary pulmonary hypertension in patients undergoing cardiac surgery and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• REVATIO (SILDENAFIL CITRATE)

Snippet

Sponsor: University of Turin, Italy | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED